Corcept Therapeutics IncorporatedCorcept Therapeutics IncorporatedCorcept Therapeutics Incorporated

Corcept Therapeutics Incorporated

No trades
See on Supercharts

CORT fundamentals

Corcept Therapeutics Incorporated key financial stats and ratios

CORT price-to-sales ratio is 9.83. The company has an Enterprise Value to EBITDA ratio of 38.00. As of 2023 they employed 352 people.

Statistics
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Price to earnings ratio
Price to cash flow ratio
Currency: USD
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Current
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios